Evidence map›Paper›PMID 35625257›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Fighting Antimicrobial Resistance: Development and Implementation of the Ghanaian National Action Plan (2017-2021).

Wolfgang Hein, Leslie Mawuli Aglanu, MacDonnel Mensah-Sekyere, Anne Harant, Johanna Brinkel, Maike Lamshöft, Eva Lorenz, Daniel Eibach, John Amuasi

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wolfgang HeinGerman Institute of Global and Area Studies (GIGA), 20354 Hamburg, Germany.
Leslie Mawuli AglanuKumasi Centre for Collaborative Research in Tropical Medicine (KCCR), PMB UPO, Kumasi, Ghana.
MacDonnel Mensah-SekyereKwame Nkrumah University of Science and Technology (KNUST), PMB UPO, Kumasi, Ghana.
Anne HarantFaculty of Business, Economics and Social Sciences, University of Hamburg, 20146 Hamburg, Germany.
Johanna BrinkelBernhard Nocht Institute for Tropical Medicine (BNITM), 20359 Hamburg, Germany.
Maike LamshöftBernhard Nocht Institute for Tropical Medicine (BNITM), 20359 Hamburg, Germany.ORCID 0000-0002-4380-9999
Eva LorenzBernhard Nocht Institute for Tropical Medicine (BNITM), 20359 Hamburg, Germany.
Daniel EibachFederal Ministry for Economic Cooperation and Development (Germany), 53113 Bonn, Germany.
John AmuasiKumasi Centre for Collaborative Research in Tropical Medicine (KCCR), PMB UPO, Kumasi, Ghana.ORCID 0000-0002-8640-2662

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, Ghana has been recognised as a leading player in addressing antimicrobial resistance (AMR) in Africa. However, based on our literature review, we could not ascertain whether the core elements of the national action plan (NAP) were implemented in practice. In this paper, we present a qualitative analysis of the development of AMR-related policies in Ghana, including the NAP. We conducted 13 semi-structured expert interviews to obtain at a more thorough understanding of the implementation process for the AMR NAP and to highlight its accomplishments and shortcomings. The results show that AMR policies, as embodied in the NAP, have led to an extended network of cooperation between stakeholders in many political fields. Broadly, limited allocation of financial resources from the government and from international cooperation have been deplored. Furthermore, the opportunity for using the NAP in mainstreaming the response to the threat of AMR has not been seized. To the general public, this remained hidden behind a number of other relevant health topics such as infection prevention, veterinary services and pharmaceutical regulation. As a One Health (OH) challenge, developing countries could integrate AMR NAPs into other health and environmental programmes to improve its implementation in practice.

Indexed as

AMR politicsantimicrobial resistanceawarenessgovernanceimplementationmobilizing financemonitoring and evaluationnational action planOne Healthtransparency

Identifiers

PMID35625257
PMCPMC9137880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.